Zunami tablets should be swallowed whole with water. It can be taken with or without food. Taking it with food may help reduce gastrointestinal upset.

Zunamifen Hydrochloride primarily acts by inhibiting the synthesis of prostaglandins by blocking cyclooxygenase (COX-1 and COX-2) enzymes, thereby reducing inflammation, pain, and fever.

• •Hypersensitivity to Zunamifen Hydrochloride or other NSAIDs
• •Active gastric or duodenal ulcer
• •Severe hepatic or renal impairment
• •Third trimester of pregnancy
• •Patients with a history of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.

Store in a cool, dry place below 30°C. Protect from light and moisture. Keep out of reach of children.

Symptoms of overdose may include nausea, vomiting, epigastric pain, lethargy, drowsiness. In severe cases, gastrointestinal bleeding, acute renal failure, or respiratory depression may occur. Management involves gastric lavage, activated charcoal, and supportive symptomatic therapy.

Pregnancy Category C (first and second trimesters), Category D (third trimester). Use during pregnancy, especially in the third trimester, is generally not recommended due to potential risks to the fetus. Consult a doctor. Small amounts may pass into breast milk; use with caution during lactation.